Driving change in inherited cardiac conditions through partnerships

Driving Change in Inherited Cardiac Conditions

Hypertrophic cardiomyopathy (HCM), a condition within the family of inherited cardiac conditions (ICCs), poses a risk for adverse outcomes and debilitating symptoms that can erode daily life.

Awareness often occurs late, and gaps in care leave families vulnerable due to variations in care delivery across the UK, resulting from a lack of standardised care pathways.

Reducing inequities and delays is crucial to prevent adverse outcomes and minimise the societal and economic burden of untreated or late-diagnosed disease.

The British Heart Foundation’s 10 Year Health Plan for England aims to improve cardiovascular care and reduce related deaths by 25% by 2035, reflecting a strong national commitment.

No specific quote available in the given text.

Author's summary: Improving care for inherited cardiac conditions through partnerships.

more

pharmaphorum pharmaphorum — 2025-11-04

More News